Auflistung nach Autor "Haag, Mathias"

Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes

Tremmel, Roman; Hofmann, Ute; Haag, Mathias; Schäffeler, Elke; Schwab, Matthias (2024)

Comprehensive metabolomic and lipidomic profiling of human kidney tissue: a platform comparison

Leuthold, Patrick; Schäffeler, Elke; Winter, Stefan; Büttner, Florian A.; Hofmann, Ute; Mürdter, Thomas E.; Rausch, Steffen; Fend, Falko; Hennenlotter, Jörg; Bedke, Jens; Schwab, Matthias; Haag, Mathias (2017)

Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers

Haag, Mathias; Hofmann, Ute; Schwab, Matthias (2023)

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

Haag, Mathias; Schwab, Matthias (2016)

Hepatic Expression of the Na+-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation

Tremmel, Roman; Nies, Anne; Van Eijck, Barbara Adriana Charlotte; Haag, Mathias; Winter, Stefan; Büttner, Florian A.; Kölz, Charlotte; Klein, Franziska; Mazzola, Pascale; Hofmann, Ute; Klein, Kathrin; Schwab, Matthias; Schäffeler, Elke (2022)

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Reustle, Anna; Di Marco, Moreno; Meyerhoff, Carolin; Nelde, Annika; Walz, Juliane S.; Winter, Stefan; Kandabarau, Siarhei; Büttner, Florian A.; Haag, Mathias; Backert, Linus; Kowalewski, Daniel Johannes; Rausch, Steffen; Hennenlotter, Jörg; Stühler, Viktoria; Scharpf, Marcus; Fend, Falko; Stenzl, Arnulf; Rammensee, Hans-Georg; Bedke, Jens; Stevanović, Stefan; Schwab, Matthias; Schäffeler, Elke (2020)

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS

Neef, Sylvia K.; Janssen, Nicole; Winter, Stefan; Wallisch, Svenja K.; Hofmann, Ute; Dahlke, Marc H.; Schwab, Matthias; Mürdter, Thomas E.; Haag, Mathias (2020)

Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial

Haag, Mathias; Schwab, Matthias (2022)

Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma

Reustle, Anna; Menig, Lena-Sophie; Leuthold, Patrick; Hofmann, Ute; Stühler, Viktoria; Schmees, Christian; Haag, Mathias; Klumpp, Verena; Winter, Stefan; Büttner, Florian A.; Rausch, Steffen; Hennenlotter, Jörg; Fend, Falko; Scharpf, Marcus; Stenzl, Arnulf; Bedke, Jens; Schwab, Matthias; Schäffeler, Elke (2022)

Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation

Nies, Anne T.; Leuthold, Patrick; Damme, Katja; Winter, Stefan; Haag, Mathias; Kruck, Stephan; Bedke, Jens; Schwab, Matthias; Schäffeler, Elke (2023)

Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS

Neef, Sylvia K.; Winter, Stefan; Hofmann, Ute; Mürdter, Thomas E.; Schäffeler, Elke; Horn, Heike; Hennenlotter, Jörg; Ott, German; Fend, Falko; Bedke, Jens; Schwab, Matthias; Haag, Mathias (2020)

Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS

Neef, Sylvia K.; Hofmann, Ute; Schwab, Matthias; Haag, Mathias; Mürdter, Thomas E. (2023)

Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na+-taurocholate cotransporting polypeptide inhibitor

Haag, Mathias; Hofmann, Ute; Heinkele, Georg; Leuthold, Patrick; Schwab, Matthias; Mürdter, Thomas E. (2015)

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202) : a multicentre, randomised, parallel-group, open-label, phase 2 trial

Haag, Mathias; Schwab, Matthias (2023)

Simultaneous Extraction of RNA and Metabolites from Single Kidney Tissue Specimens for Combined Transcriptomic and Metabolomic Profiling

Leuthold, Patrick; Schwab, Matthias; Hofmann, Ute; Winter, Stefan; Rausch, Steffen; Hennenlotter, Jörg; Bedke, Jens; Schäffeler, Elke; Haag, Mathias (2018)

Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia

Fujiwara, Ryoichi; Haag, Mathias; Zanger, Ulrich M.; Schwab, Matthias; Schäffeler, Elke; Nies, Anne (2018)

The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Haag, Mathias; Schwab, Matthias (2018)

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib/IIa study

Haag, Mathias; Schwab, Matthias (2016)

Untargeted stable isotope-resolved metabolomics to assess the effect of PI3Kβ inhibition on metabolic pathway activities in a PTEN null breast cancer cell line

Lackner, Marcel; Neef, Sylvia K.; Winter, Stefan; Beer-Hammer, Sandra; Schwab, Matthias; Hofmann, Ute; Haag, Mathias; Nürnberg, Bernd (2022)

Auflistung nach Autor "Haag, Mathias"

Auflistung nach Autor "Haag, Mathias"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos